Cargando…
Is Obesity a Risk Factor for Vaccine Non-Responsiveness?
Understanding the link between vaccine immunogenicity and efficacy is currently a major focus in HIV research. Consequently, recent developments in the HIV-1 vaccine field have led to a closer look at immune responses to known efficacious vaccines. We undertook a study to explore clinical predictors...
Autores principales: | Young, Katherine M., Gray, Clive M., Bekker, Linda-Gail |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859613/ https://www.ncbi.nlm.nih.gov/pubmed/24349359 http://dx.doi.org/10.1371/journal.pone.0082779 |
Ejemplares similares
-
Hope for HIV control in southern Africa: The continued quest for a vaccine
por: Bekker, Linda-Gail, et al.
Publicado: (2017) -
Review of preventative HIV vaccine clinical
trials in South Africa
por: Laher, Fatima, et al.
Publicado: (2020) -
Virological Breakthrough: A Risk Factor for Loss to Followup in a Large Community-Based Cohort on Antiretroviral Therapy
por: Orrell, Catherine, et al.
Publicado: (2011) -
Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa
por: Collie, Shirley, et al.
Publicado: (2021) -
DNA vaccines join the fight against COVID-19
por: Blakney, Anna K, et al.
Publicado: (2022)